Mycronic Doubles Long-Term Revenue Target to SEK 20 Billion, Launches Photomask Inspection Tool to Challenge KLA and Lasertec
Capital Markets Day, August 31, 2026 — Stockholm
Mycronic used its Capital Markets Day on August 31 to lay out a new long-term financial target of SEK 20 billion in revenue, roughly double the SEK 10 billion goal set at its last investor day in 2022, with management targeting the milestone sometime between 2032 and 2035 while holding EBIT margin at approximately 25%. The Swedish electronics-production equipment maker also unveiled two new products in its core Pattern Generators division, including its first-ever move into photomask inspection, a market currently dominated by KLA and Lasertec. Taken together, the update signals a company leaning harder into AI-infrastructure-linked demand while acknowledging that some of the current growth may not persist at today's pace.
New SEK 20 Billion Target Assumes Cyclicality, Doesn't Pin a Single Year
CFO Pierre Brorsson confirmed the company has essentially hit its previous SEK 10 billion sales ambition and its SEK 2 billion profit target set in 2022, though sales are still "closing in" on the full figure. The new goal doubles the top line again, built on the same growth cadence the company has posted historically: 15% average annual revenue growth over the past decade, split roughly two-thirds organic and one-third from acquisitions. Management was explicit about why it chose a multi-year window rather than a single target year. CEO Anders Lindqvist explained that the 2020 COVID shock erased one to two years of accumulated growth unexpectedly, and the company does not want to be pinned to a single year "because we don't really know when we hit the peak or valley" in what remains a cyclical industry.
Notably, management conceded that AI demand is currently flattering the numbers. When pressed by DNB Carnegie's Mikael Laséen on how dependent the SEK 20 billion target is on AI data center infrastructure spending continuing at current levels, Lindqvist offered an unusually candid admission: "I think even Charlott mentioned that other applications for PG is even AI-driven... in the current number, maybe we are a little bit ahead of our target because of AI demand. So if that boost that we have seen now was not there, I think we would have reached this target that we currently have reached maybe six months later." That is a meaningful data point for investors trying to model how much of Mycronic's current momentum is structural versus cyclical AI capex.
IQX Inspection Tool Marks First Direct Confrontation With KLA and Lasertec
The most consequential product announcement was IQX, a new photomask inspection machine that pushes Pattern Generators into an entirely new market adjacent to its core mask-writing business. Division head Mikael Wahlsten sized the addressable inspection market at roughly $125 million, supported today by an installed base of around 400 legacy machines, many installed 20 to 30 years ago, creating what he called "a big replacement opportunity" on top of underlying growth. Mycronic's ambition is to capture 40% of that market. Wahlsten estimated that around half of all semiconductor photomasks could pass through an IQX-class machine at least once, underscoring the size of the prize, and said internally the inspection opportunity "could be even larger than the SLX business long term." The strategic logic leans heavily on reusing SLX platform components: control systems, software, pattern-preparation logic, and shared optics partners. New investment went into advanced optics and GPU-based computational analysis, with Wahlsten noting the team has been building out AI-supported capabilities directly into the product. When an SEB analyst pushed on how Mycronic differentiates against much larger incumbents, Wahlsten's answer was measured rather than triumphant: "they are large companies... but also they are focused very much on the high end," implying Mycronic's angle is the broader, less-served mid-node segment. First customer revenue is not expected until 2027.
Next-Generation SLX Doubles Beam Count, But Pricing Stays Roughly Flat Per Unit of Capacity
Mycronic also launched the next generation of its SLX laser mask writer, increasing beam count from 15 to 29 to lift throughput, alongside expanded software capability to write more mask layers. Wahlsten disclosed that Mycronic has sold 75 SLX systems cumulatively, with roughly one-third going into high-end applications including second-layer writes on the most advanced EUV masks — a detail that matters because it shows the "mature node" product has real traction in leading-edge fabs, where AI chip demand is concentrated. On unit economics, Wahlsten was direct: customers who choose to match the old machine's throughput and capability will pay a similar price, meaning the uplift is not being priced as a discount — "you will pay roughly the same price for the capacity as you did before." The benefit to customers instead comes through cleanroom footprint savings, since packing more capacity into expensive cleanroom space is itself valuable, and the new throughput is software-tunable so customers can scale output later without buying additional hardware. A follow-up exchange with an unnamed analyst probed whether the replacement cycle is accelerating quickly enough to justify the growth narrative — pointing out that at roughly 15-16 units shipped annually, closing out the addressable laser-based portion of the roughly 500-tool global photomask writer installed base would take four to five years. Management's response reframed the claim: the "soon half the market" comment referred to Mycronic's tools accounting for half of laser-writing *capacity*, not half of installed units, given the newer machines' higher throughput per tool.
PCB Assembly Solutions Margin Shortfall Gets a Named Fix, With a Cost and a Deadline
Not every division is firing. PCB Assembly Solutions, Mycronic's high-mix, low-volume assembly equipment business, fell below its 10% profitability threshold last year amid what division head Clemens Jargon described as "prolonged-term weakness" in industrial markets, particularly in Europe. Management has launched a formal profitability improvement program costing roughly SEK 100 million in product contribution, targeting gross margin improvement, business mix optimization, and organizational scalability. The explicit deadline: profitability above 10%, stable and reliable, by the end of 2027. Investors should treat this as a concrete, time-bound commitment rather than a vague turnaround promise, and the SEK 100 million cost figure gives a clean marker to track execution against.
Global Technologies Is Now an AI Story in All But Name
Magnus Marthinsson, who has run the Global Technologies division for three and a half years, disclosed that four of the division's five business lines are now primarily driven by AI infrastructure buildout: PCB Test (from the atg acquisition), Die Bonding (MRSI), Applied Plasma (Surfx), and Photonic Interconnects (Vanguard Automation). Only Magnetic Test, built on last year's Hprobe acquisition in France, sits outside the AI theme, instead riding MRAM adoption and automotive electrification. PCB Test remains the largest business line, contributing "a little bit more than half" of divisional revenue today, a mix Marthinsson expects to persist near-term even as he expects the newer, AI-exposed lines to gain share over time. On gross margin mix within Global Technologies, Brorsson disclosed that Surfx was accretive to the segment average at acquisition, while Photonic Interconnects is currently running below average and Magnetic Test is roughly on par — useful granularity for investors modeling the path to the division's above-30% margin target, though Brorsson cautioned that near-term ramp in Surfx is unlikely to shift the overall divisional mix materially given its early stage. One structural caveat worth flagging: Marthinsson noted PCB Test's growth is partly tied to a factory buildout wave in Southeast Asia that "will not continue forever," a rare acknowledgment that a piece of current demand is capacity-driven and finite rather than purely secular.
High Volume's China Business Targets 18% Organic CAGR, Pushes Into Semiconductor Packaging
Ivan Li, general manager of the High Volume division's Axxon brand in China, detailed a business that has grown revenue more than tenfold over ten years under Mycronic ownership, moving from the sixth-ranked position in electronic dispensing to the number one market share holder, which Li put at 44% share against a fragmented base of smaller automation players. The division is targeting greater than 18% organic CAGR over the next five years and aims to lift overseas revenue contribution to 15% from essentially zero a decade ago, with a new Thailand factory now operational to support that push. Li also flagged a new growth avenue: entry into semiconductor packaging, which he tied to "domestic EV, AI and advanced packaging and also the Chinese semiconductor self-sufficiency push." A new facility now under construction in China is sized, according to Li, to support up to $500 million in output value, a concrete capacity ceiling investors can use to gauge the division's medium-term growth runway. One structural risk Li raised unprompted: intellectual property protection in the Chinese market is weak, meaning competitors can copy new products quickly, forcing Axxon into a faster product-refresh cycle than its Western peers face.
M&A Will Skew Toward Back-End Semiconductor, Not Front-End Wafer Fab
On capital allocation, Brorsson said Mycronic's acquisition focus going forward will prioritize the semiconductor value chain, "most probably more of the back-end Semicon than the front-end Semicon." This is a meaningful clarification for investors trying to handicap where the next bolt-on might land, given the company's recent acquisitions of Cowin (Korea, photomask repair and wafer inspection), Vanguard Automation (photonic interconnects), Surfx (plasma cleaning) and Hprobe (magnetic test) have already stretched the platform across several adjacent niches. Management reiterated it will not acquire simply to hit a growth-rate target, with Lindqvist noting the additional 5 percentage points of growth needed to bridge organic delivery to the full 20% ambition "we will not really steer... as a target."